Lidegaard, Øjvin; Øjvind Lidegaard, Lars Hougaard Nielsen, Charlotte Wessel Skovlund, and Ellen Løkkegaard (2012). "Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10". BMJ 344: 1–9. doi:10.1136/bmj.e2990. PMID 22577198.
nih.gov
ncbi.nlm.nih.gov
HJ Ahrendt, I. Nisand, C. Bastianelli et al.: Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006 Dec;74(6):451–7. PMID 17157101
NN Sarkar: The combined contraceptive vaginal device (NuvaRing): a comprehensive review. Eur J Contracept Reprod Health Care. 2005 Jun;10(2):73–8. PMID 16147810
van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC: Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception. 2005 Sep;72(3):168-174. PMID 16102549
Lidegaard, Øjvin; Øjvind Lidegaard, Lars Hougaard Nielsen, Charlotte Wessel Skovlund, and Ellen Løkkegaard (2012). "Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10". BMJ 344: 1–9. doi:10.1136/bmj.e2990. PMID 22577198.
